EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

Protocol for 3D screening of lung cancer spheroids using natural products

Virneliz Fernández Vega, Dong Yang, Luis Ortiz Jordán, Fei Ye, Louis Conway, Li Yun Chen, Justin Shumate, Pierre Baillargeon, Louis Scampavia, Christopher Parker, Ben Shen, Timothy P Spicer

SLAS Discovery · 2023-03 · 28 (2) · 20-28

DOI: 10.1016/j.slasd.2023.01.005 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift SLAS Discovery, 2023-03. Verfasst von Virneliz Fernández Vega und 11 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Screening Center, Department of Molecular Medicine, UF Scripps Biomedical Research, Jupiter, FL, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Biological Products, Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and accounts for ∼84% of all lung cancer cases. NSCLC remains one of the leading causes of cancer-associated death, with a 5-year survival rate less than 25%. This type of cancer begins with healthy cells that change and start growing out of control, leading to the formation of lesions or tumors. Understanding the dynamics of how the tumor microenvironment promotes cancer initiation and progression that leads to cancer metastasis is crucial to help identify new molecular therapies. 3D primary cell tumor models have received renewed recognition due to their ability to better mimic the complexity of in vivo tumors and as a potential bridge between traditional 2D culture and in vivo studies. Vast improvements in 3D cell culture technologies make them much more cost effective and efficient largely because of the use of a cell-repellent surfaces and a novel angle plate adaptor technology. To exploit this technology, we accessed the Natural Products Library (NPL) at UF Scripps, which consists of crude extracts, partially purified fractions, and pure natural products (NPs). NPs generally are not very well represented in most drug discovery libraries and thus provide new insights to discover leads that could potentially emerge as novel molecular therapies. Herein we describe how we combined these technologies for 3D screening in 1536 well format using a panel of ten NSCLC cells lines (5 wild type and 5 mutant) against ∼1280 selected members of the NPL. After further evaluation, the selected active hits were prioritized to be screened against all 10 NSCLC cell lines as concentration response curves to determine the efficacy and selectivity of the compounds between wild type and mutant 3D cell models. Here, we demonstrate the methods needed for automated 3D screening using microbial NPs, exemplified by crude extracts, partially purified fractions, and pure NPs, that may lead to future use targeting human cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungBiological ProductsAntineoplastic AgentsHumansDrug Screening Assays, AntitumorSpheroids, CellularEarly Detection of CancerTumor Microenvironment

Stichwörter der Autor:innen

Angle adaptorHTSMagnetic bioprintingNon-small lung cancerOrganoidPhenotypic

Substanzen

Biological ProductsAntineoplastic Agents

Autor:innen und Institutionen

  • Molecular Screening Center, Department of Molecular Medicine, UF Scripps Biomedical Research, Jupiter, FL, USA.
  • Department of Chemistry, UF Scripps Biomedical Research, Jupiter, FL, USA; Natural Products Discovery Center, UF Scripps Biomedical Research, Jupiter, FL, USA.
  • Department of Chemistry, UF Scripps Biomedical Research, Jupiter, FL, USA.
  • Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA.
  • Molecular Screening Center, Department of Molecular Medicine, UF Scripps Biomedical Research, Jupiter, FL, USA. Electronic address: spicert@ufl.edu.

Förderung

  • NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS

Zitieren

APA

Vega, V. F., Yang, D., Jordán, L. O., Ye, F., Conway, L., Chen, L. Y., Shumate, J., Baillargeon, P., Scampavia, L., Parker, C., Shen, B., & Spicer, T. P. (2023). Protocol for 3D screening of lung cancer spheroids using natural products. SLAS Discovery, 28(2), 20-28. https://doi.org/10.1016/j.slasd.2023.01.005

Vancouver

Vega VF, Yang D, Jordán LO, Ye F, Conway L, Chen LY, et al. Protocol for 3D screening of lung cancer spheroids using natural products. SLAS Discovery. 2023;28(2):20-28. doi:10.1016/j.slasd.2023.01.005

BibTeX
@article{Vega2023,
  author = {Vega, Virneliz Fernández and Yang, Dong and Jordán, Luis Ortiz and Ye, Fei and Conway, Louis and Chen, Li Yun and Shumate, Justin and Baillargeon, Pierre and Scampavia, Louis and Parker, Christopher and Shen, Ben and Spicer, Timothy P},
  title = {Protocol for 3D screening of lung cancer spheroids using natural products},
  journal = {SLAS Discovery},
  year = {2023},
  volume = {28},
  number = {2},
  pages = {20--28},
  doi = {10.1016/j.slasd.2023.01.005}
}
Kostenlos starten →